Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Notice of Nexstim Plc 2017 Full Year Results | ||
By: Nasdaq / GlobeNewswire - 16 Feb 2018 | Back to overview list |
|
Company announcement, Helsinki, 16 February 2018, at 9 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, will announce its full year results for the year ended 31 December 2017 on Wednesday 28 February 2018 at 9.00 am Finnish time. A conference call for analysts, investors and media will take place at 15:00 Finnish time (EET) on Wednesday 28 February 2018, hosted by Martin Jamieson, Chairman of the Board and CEO, and Mikko Karvinen, CFO, who will present the financial and operational results followed by a Q&A session. The dial-in numbers for the conference call are: The call password is Nexstim NEXSTIM PLC Further information is available on the website www.nexstim.com or by telephone: Nexstim +447715163942 Citigate Dewe Rogerson +44 (0)207 2822949 About Nexstim Plc Nexstim has received clearance from the FDA for marketing and commercial distribution of its NBT® system for the treatment of Major Depressive Disorder (MDD) and looks forward to introducing the NBT® system for this important indication during H1 2018. The NBT® system is currently in a 60 patient, supplemental Phase III study, E-FIT trial, for its use in stroke rehabilitation. The trial is expected to complete in Q2 2018, allowing Nexstim to file for FDA clearance. FDA clearance would allow Nexstim to start marketing and selling its NBT® system for stroke rehabilitation in the USA. Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com Attachments:http://www.globenewswire.com/NewsRoom/AttachmentNg/8fd051d5-e8fe-42a9-ad4a-323dced77245 |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |